MBBS in Russia | MBBS in Moscow | Study Pulmonology in Russia | Study Pulmonology in Moscow | Pulmonology Education in Russia | Pulmonology Education in Moscow | MBBS Admission in I.M. Sechenov First Moscow State Medical University | MBBS Fee in I.M. Sechenov First Moscow State Medical University | Apply for MBBS Admission in I.M. Sechenov First Moscow State Medical University | How to Get Direct Admission in MBBS in I.M. Sechenov First Moscow State Medical University | Study Pulmonology in I.M. Sechenov First Moscow State Medical University | Pulmonology Fee in I.M. Sechenov First Moscow State Medical University | About Pulmonology in I.M. Sechenov First Moscow State Medical University

The Department of Pulmonology and the Clinic of Pulmonology and Respiratory Medicine were established in November 2017. The advisory and therapeutic activities of the staff of the Department and the Clinic of Pulmonology and Respiratory Medicine are carried out in the conditions of the pulmonary, consultative and diagnostic departments and the Department of Functional Diagnostics of the University Clinical Hospital №4. The department consists of 8 employees, including 2 professors, 3 doctors of science and 5 candidates of medical sciences. Professors and teachers have extensive experience in pedagogical and educational work, being simultaneously practicing pulmonologists. The Head of the Department and the Head of the Clinic of Pulmonology and Respiratory Medicine is one of the leading specialists in our country in respiratory diseases; Corresponding Member of the Russian Academy of Sciences, Professor, Ph.D. Avdeev Sergey Nikolaevich. The main directions of the research work of the department are: the development and introduction of new methods for the diagnosis and treatment of respiratory diseases; development and implementation of preventive programs for respiratory diseases; study of risk factors for bronchopulmonary diseases; the study of rare and genetically determined diseases of the lungs; diagnostics, evaluation of the efficacy and safety of new drugs in patients with pulmonary hypertension; creation of educational programs for patients with bronchial asthma and COPD; development and evaluation of the efficacy and safety of new drugs, new methods of drug delivery to the respiratory tract, optimization of new methods of respiratory support for patients with severe forms of diseases and respiratory failure.